SCHEMBL5205433

SCHEMBL5205433

COCC(COC)N(C)Cc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 1/20 0.52
KCNH2 Q12809 5/20 0.50
CRHBP P24387 2/20 0.50
CRHR2 Q13324 2/20 0.50
IDO1 P14902 2/20 0.42
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.42
TSHR P16473 2/20 0.40
ACHE P22303 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
PHLPP2 Q6ZVD8 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KCNJ1 P48048 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5204583 0.81 CRHBP (0.53) PYCR1KCNH2CRHBPCRHR2ALDH1A1
SCHEMBL3158691 0.77 KCNH2 (0.66) PYCR1KCNH2CRHBPCRHR2IDO1
SCHEMBL3144616 0.75 KCNH2 (0.52) PYCR1KCNH2CRHBPCRHR2IDO1
SCHEMBL629014 0.75 KCNH2 (0.52) PYCR1KCNH2CRHBPCRHR2IDO1
SCHEMBL5208558 0.75 KCNH2 (0.71) PYCR1KCNH2CRHBPCRHR2ALDH1A1
SCHEMBL3153458 0.75 CRHBP (0.64) PYCR1KCNH2CRHBPCRHR2IDO1
Hydrochloric Acid SCHEMBL28581917 0.73 CRHBP (0.62) PYCR1KCNH2CRHBPCRHR2IDO1
SCHEMBL3440739 0.73 PYCR1 (0.56) PYCR1KCNH2CRHBPCRHR2IDO1
SCHEMBL3156425 0.72 KCNH2 (0.60) PYCR1KCNH2CRHBPCRHR2ACHE
SCHEMBL3162128 0.72 KCNH2 (0.63) PYCR1KCNH2CRHBPCRHR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040103-B1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2007-03-14 EP disclosed
US-6413947-B1 Anilide derivative, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-02 US disclosed
US-6268354-B1 Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-07-31 US disclosed
CN-1282243-A Pharmaceutical composition containing anilide derivative for antagonizing CCR5 TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2001-01-31 CN disclosed
US-6172061-B1 AIDS THERAPY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-01-09 US disclosed
US-6166006-A Anilide derivative, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-12-26 US disclosed
EP-1039899-A2 PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE Takeda Chemical Industries, Ltd. (JP) 2000-10-04 EP disclosed
EP-1040103-A1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-10-04 EP disclosed
WO-1999032100-A2 PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-01 WO disclosed
WO-1999032468-A1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-01 WO disclosed